194 related articles for article (PubMed ID: 36765502)
1. [Retrospective Analysis of Irregular Antibodies Causing Hemolytic Disease of the Fetus and Newborn in Jiangxi Province].
Liu X; LE F; Wang LH; Shu J; Xu XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):215-220. PubMed ID: 36765502
[TBL] [Abstract][Full Text] [Related]
2. A single-center, retrospective analysis of 17 cases of hemolytic disease of the fetus and newborn caused by anti-M antibodies.
He Y; Gao W; Li Y; Xu C; Wang Q
Transfusion; 2023 Mar; 63(3):494-506. PubMed ID: 36727659
[TBL] [Abstract][Full Text] [Related]
3. [Investigation and Analysis of Non-ABO Hemolytic Disease of the Newborn].
Zheng YL; Hong Q; Wang QM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1330-1333. PubMed ID: 34362525
[TBL] [Abstract][Full Text] [Related]
4. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
5. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
[TBL] [Abstract][Full Text] [Related]
6. Statistical model for prediction of ABO hemolytic disease of the fetus and newborn in India.
Patale DS; Lokhande TL; Chaudhary RK
Immunohematology; 2021 Jun; 37(2):64-68. PubMed ID: 34170645
[TBL] [Abstract][Full Text] [Related]
7. Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study.
Lu W; Ziman A; Yan MTS; Waters A; Virk MS; Tran A; Tang H; Shih AW; Scally E; Raval JS; Pandey S; Pagano MB; Shan H; Moore C; Morrison D; Cormack O; Fitzgerald J; Duncan J; Corean J; Clarke G; Yazer M
Transfusion; 2023 Apr; 63(4):817-825. PubMed ID: 36815517
[TBL] [Abstract][Full Text] [Related]
8. Anti-C causing severe hemolytic disease of the fetus and newborn: a rare case report.
Sahoo D; Anuragaa S; Abhishekh B
Immunohematology; 2023 Apr; 39(1):11-14. PubMed ID: 37017597
[TBL] [Abstract][Full Text] [Related]
9. Clinical significances and distribution of unexpected antibodies found in infants.
Kim HJ; Seo SW; Chung Y; Kim H; Hwang SH; Oh HB; Ko DH
Transfus Apher Sci; 2023 Oct; 62(5):103765. PubMed ID: 37532599
[TBL] [Abstract][Full Text] [Related]
10. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
[TBL] [Abstract][Full Text] [Related]
11. Maternal Cold-Reacting Immunoglobulin G Anti-M of MNS Blood Group System Causing Hemolytic Disease of the Fetus.
Liang YL; Shi Y; Su YQ; Wu F; Liang Y; Fan X; Lin J; Liu Y; Long P; Ren J; Liang S
Iran J Immunol; 2023 Mar; 20(1):129-134. PubMed ID: 36934323
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years.
Matteocci A; De Rosa A; Buffone E; Pierelli L
Transfus Med; 2019 Jun; 29(3):197-201. PubMed ID: 29369480
[TBL] [Abstract][Full Text] [Related]
13. History and current standard of postnatal management in hemolytic disease of the fetus and newborn.
De Winter DP; Hulzebos C; Van 't Oever RM; De Haas M; Verweij EJ; Lopriore E
Eur J Pediatr; 2023 Feb; 182(2):489-500. PubMed ID: 36469119
[TBL] [Abstract][Full Text] [Related]
14. Hemolytic disease in fetuses and newborns due to antibodies against the M-antigen.
Páez M; Jiménez M; Corredor A
Biomedica; 2021 Dec; 41(4):643-650. PubMed ID: 34936250
[TBL] [Abstract][Full Text] [Related]
15. Jk3 alloantibodies during pregnancy-blood bank management and hemolytic disease of the fetus and newborn risk.
Lawicki S; Coberly EA; Lee LA; Johnson M; Eichbaum Q
Transfusion; 2018 May; 58(5):1157-1162. PubMed ID: 29479723
[TBL] [Abstract][Full Text] [Related]
16. Hemolytic disease of the fetus and newborn caused by irregular antibody: A mortality case report and case series during the past 15 years in NCKUH.
Chuang MT; Chang CH
Taiwan J Obstet Gynecol; 2022 Sep; 61(5):896-899. PubMed ID: 36088064
[TBL] [Abstract][Full Text] [Related]
17. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
Front Immunol; 2021; 12():698541. PubMed ID: 35003054
[TBL] [Abstract][Full Text] [Related]
18. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
Rath ME; Smits-Wintjens VE; Lindenburg IT; Folman CC; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
Transfusion; 2013 Jul; 53(7):1580-5. PubMed ID: 23113703
[TBL] [Abstract][Full Text] [Related]
19. Title: Effect of multiple maternal red cell alloantibodies on the occurrence and severity of Hemolytic Disease of the Fetus and Newborn.
Singh B; Chaudhary R; Katharia R
Transfus Apher Sci; 2021 Feb; 60(1):102958. PubMed ID: 33039278
[TBL] [Abstract][Full Text] [Related]
20. Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland.
Susila S; Ilmakunnas M; Lauronen J; Vuorinen P; Ångerman S; Sainio S
Transfusion; 2024 May; 64 Suppl 2():S119-S125. PubMed ID: 38240146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
